FASN is the key enzyme for the control of fatty acid synthesis that contributes significantly to prostate cancer progression, and FASN was observed to be relatively high in castrated mouse xenograft tissues compared to intact ones (Figure S4A). Here, FASN is linked to prostate carcinoma.